- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Patrick Conway: How VBID Can Benefit Medicare Advantage
Patrick Conway, MD, explains why CMS looked toward value-based insurance design for Medicare Advantage plans.
Patrick Conway, MD, says that CMS is looking towards value-based insurance design for Medicare Advantage plans.
Transcript (modified)
What is it about value-based insurance design that CMS thought would make it a good fit for a Medicare Advantage Demonstration?
So we had seen value-based insurance design in the private market, we’d seen some evidence of its potential to improve quality, to lower cost, and to increase delivery of high-value services. And we’re hearing from Medicare Advantage (MA) Plans that they wanted the ability to have value-based insurance design in the MA program.
So we put forward that model where, in the process of getting applications and selecting those applications, we think incentivizing the consumer, the beneficiary, to seek out high-value services will be beneficial to Medicare Advantage plans and to our health system.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
